215 related articles for article (PubMed ID: 31531807)
1. Efficacy and safety of the new antiviral agents for the treatment of hepatitis C virus infection in Egyptian renal transplant recipients.
Maghrabi HME; Elmowafy AY; Refaie AF; Elbasiony MA; Shiha GE; Rostaing L; Bakr MA
Int Urol Nephrol; 2019 Dec; 51(12):2295-2304. PubMed ID: 31531807
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study.
Saxena V; Khungar V; Verna EC; Levitsky J; Brown RS; Hassan MA; Sulkowski MS; O'Leary JG; Koraishy F; Galati JS; Kuo AA; Vainorius M; Akushevich L; Nelson DR; Fried MW; Terrault N; Reddy KR
Hepatology; 2017 Oct; 66(4):1090-1101. PubMed ID: 28504842
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.
Lin MV; Sise ME; Pavlakis M; Amundsen BM; Chute D; Rutherford AE; Chung RT; Curry MP; Hanifi JM; Gabardi S; Chandraker A; Heher EC; Elias N; Riella LV
PLoS One; 2016; 11(7):e0158431. PubMed ID: 27415632
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C.
Fernández I; Muñoz-Gómez R; Pascasio JM; Baliellas C; Polanco N; Esforzado N; Arias A; Prieto M; Castells L; Cuervas-Mons V; Hernández O; Crespo J; Calleja JL; Forns X; Londoño MC
J Hepatol; 2017 Apr; 66(4):718-723. PubMed ID: 28039098
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of HCV infected kidney transplant recipients receiving direct-acting antiviral agents: a single-center experience in China.
Zhang J; Sun W; Lin J; Tian Y; Ma L; Zhang L; Zhu Y; Qiu W
BMC Infect Dis; 2019 Jul; 19(1):645. PubMed ID: 31324230
[TBL] [Abstract][Full Text] [Related]
6. High rate of acute kidney injury in patients with chronic kidney disease and hepatitis C virus genotype 4 treated with direct-acting antiviral agents.
Elmowafy AY; El Maghrabi HM; Mashaly ME; Eldahshan KF; Rostaing L; Bakr MA
Int Urol Nephrol; 2019 Dec; 51(12):2243-2254. PubMed ID: 31612423
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Chronic Hepatitis C Infection Among Egyptian Kidney Transplant Recipients: A Pilot Study.
El Maghrabi HM; Elmowafy AY; Donia AF; Ismail MI; El-Hendy YA; Soliman R; Shiha GE; Bakr MA
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):62-67. PubMed ID: 30777525
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection.
Xue Y; Zhang LX; Wang L; Li T; Qu YD; Liu F
World J Gastroenterol; 2017 Aug; 23(32):5969-5976. PubMed ID: 28932089
[TBL] [Abstract][Full Text] [Related]
9. Use of Sofosbuvir-Based Treatment of Chronic Hepatitis C in Liver Transplant Recipients on Hemodialysis.
Saab S; A Jimenez M; N Bau S; Choi G; Durazo FA; M El-Kabany M; Han SB; Busuttil RW
J Clin Gastroenterol; 2017 Feb; 51(2):167-173. PubMed ID: 27548734
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of chronic hepatitis C infection with directly acting antivirals in renal transplant recipients.
Taneja S; Duseja A; De A; Kumar V; Ramachandran R; Sharma A; Dhiman RK; Gupta KL; Chawla Y
Nephrology (Carlton); 2018 Sep; 23(9):876-882. PubMed ID: 28703905
[TBL] [Abstract][Full Text] [Related]
11. Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient.
Chute DF; Chung RT; Sise ME
Kidney Int; 2018 Mar; 93(3):560-567. PubMed ID: 29325996
[TBL] [Abstract][Full Text] [Related]
12. [Novel antiviral agents for the treatment of HCV among renal transplant recipients].
Fabrizi F; Donato FM; Messa P
G Ital Nefrol; 2017 Aug; 34(4):35-50. PubMed ID: 28762681
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic hepatitis C viral infection with sofosbuvir and daclatasvir in kidney transplant recipients.
Huang H; Tang H; Deng H; Shen J; Zhou Q; Xie W; Wu J; Chen J
Transpl Infect Dis; 2019 Feb; 21(1):e13018. PubMed ID: 30369001
[TBL] [Abstract][Full Text] [Related]
14. Safety, efficacy and cost of two direct-acting antiviral regimens: A comparative study in chronic hepatitis C Egyptian patients.
Ibrahim Mohammed Ebid AH; Ashraf Ahmed O; Hassan Agwa S; Mohamed Abdel-Motaleb S; Mohamed Elsawy A; Hagag RS
J Clin Pharm Ther; 2020 Jun; 45(3):539-546. PubMed ID: 31889322
[TBL] [Abstract][Full Text] [Related]
15. Eradication of hepatitis C virus infection in kidney transplant recipients using direct-acting antiviral therapy: Qatar experience.
Alkadi MM; Abuhelaiqa EA; Elshirbeny MF; Hamdi AF; Fituri OM; Asim M; Alkaabi SR; Derbala MF; Jarman ME; Ashour AM; Nauman A; Al Maslamani YK; Butt AA; Al-Malki HA
Immun Inflamm Dis; 2021 Mar; 9(1):246-254. PubMed ID: 33264509
[TBL] [Abstract][Full Text] [Related]
16. The effect of anemia on the efficacy and safety of treating chronic hepatitis C infection with direct-acting antivirals in patients with chronic kidney disease.
Elmowafy AY; Abbas MH; Denewar AA; Mashaly ME; Shiha G; El Wasif SM; Rostaing L; Bakr MA
Int Urol Nephrol; 2021 Apr; 53(4):749-761. PubMed ID: 33111161
[TBL] [Abstract][Full Text] [Related]
17. Eliminating Hepatitis C Virus From a Prevalent Kidney Transplant Recipient Population: A Single-Center Study in Belgium in the Direct-Acting Antivirals Era.
Devresse A; Delire B; Lazarus JV; Kabamba B; De Meyer M; Mourad M; Buemi A; Darius T; Cambier JF; Goffin E; Jadoul M; Kanaan N
Transplant Proc; 2020 Apr; 52(3):815-822. PubMed ID: 32143864
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation.
Kamar N; Marion O; Rostaing L; Cointault O; Ribes D; Lavayssière L; Esposito L; Del Bello A; Métivier S; Barange K; Izopet J; Alric L
Am J Transplant; 2016 May; 16(5):1474-9. PubMed ID: 26587971
[TBL] [Abstract][Full Text] [Related]
19. Effect of cyclosporine A versus tacrolimus on the response to antiviral therapy after hepatitis C genotype-4 recurrence post-liver transplantation: A prospective cohort trial.
El-Hamamsy M; Montasser IF; Mansy AE; Nabet DE; El-Meteini M
J Clin Pharm Ther; 2019 Jun; 44(3):447-453. PubMed ID: 30714175
[TBL] [Abstract][Full Text] [Related]
20. Chronic Hepatitis C Virus Infection After Kidney Transplantation With or Without Direct-Acting Antivirals in a Real-Life Setting: A French Multicenter Experience.
Chevallier E; Büchler M; Caillard S; Bouvier N; Colosio C; Rivalan J; Sayegh J; Bertrand D; Le Meur Y; Thierry A; Garrouste C; Rerolle JP; Rostaing L; Gatault P
Transplant Proc; 2020 Dec; 52(10):3179-3185. PubMed ID: 32636068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
